---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-115263"
form_type: "8-K"
ticker: "ASTH"
cik: "0001083446"
company_name: "Astrana Health, Inc."
filed_at: "2023-11-07T23:59:59+00:00"
generated_at: "2026-06-08T13:20:28.569651+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# ApolloMed Q3 revenue $348.2M (+10% YoY), EPS $0.47; acquires CFC for ~$202M

## Summary
- Total revenue $348.2M (+10% YoY); net income $22.1M ($0.47 diluted EPS) vs $23.2M ($0.50).
- Adjusted EBITDA $52.0M (15% margin) vs $57.1M; full-year guidance narrowed to $1.34-1.39B revenue.
- Agreed to acquire Community Family Care (200k+ members) for ~$202M cash/equity; expected close Q1 2024.
- Entered $300M term loan amendment to expand credit facility to $700M; $100M stock repurchase from APC.
- Partnerships: Associated Hispanic Physicians (~25k members), Advantage Health Network, Wider Circle CalAIM.

## SEC filing metadata
- accession: 0001104659-23-115263
- form_type: 8-K
- ticker: ASTH
- cik: 0001083446
- company_name: Astrana Health, Inc.
- filed_at: 2023-11-07T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1083446/000110465923115263/0001104659-23-115263-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1083446/000110465923115263/tm2330057d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-115263
- JSON: https://secwatch.observer/filing/0001104659-23-115263.json
- Plain text: https://secwatch.observer/filing/0001104659-23-115263.txt

## Key facts
- Earnings Releases
  Astrana Health, Inc. reported third quarter ended September 30, 2023 results: revenue $348.2 million, net income $22.1 million, EPS $0.47.
  - Period: third quarter ended September 30, 2023
  - Revenue: $348.2 million
  - Net income: $22.1 million
  - EPS: $0.47
  - Result: reported results
  source text: ahead.” Financial Highlights for Third Quarter Ended September 30, 2023: All comparisons are to the quarter ended September 30, 2022 unless otherwise stated. · Total revenue of $348.2 million, up 10% from $317.0 million · Care Partners revenue of $326.5 million, up 11% from $293.6 million · Net income attributable to ApolloMed of $22.1 million, compared to $23.2
  evidence_url: https://www.sec.gov/Archives/edgar/data/1083446/000110465923115263/0001104659-23-115263-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.